What is Gracell Biotechnologies Inc. (GRCL) stock price today?

Gracell Biotechnologies Inc. (GRCL) currently trades at $10.25 per share. The stock has a market capitalization of $989.87M and a P/E ratio of —x.

Is GRCL stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Gracell Biotechnologies Inc. has a Smart Value Score of 24/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

GRCL

Gracell Biotechnologies Inc.

NASDAQ: GRCL · HEALTHCARE · BIOTECHNOLOGY

$10.25

+0.00% today

Updated 2026-04-30

Market cap

$989.87M

P/E ratio

—

P/S ratio

732.21x

EPS (TTM)

$-0.97

Dividend yield

—

52W range

$307 – $525

Volume

6.4M

Market cap

$989.87M

P/E ratio

—

P/S ratio

732.21x

EPS (TTM)

$-0.97

Dividend yield

—

52W range

$307 – $525

Volume

6.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$10.58

+3.22%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

Key financials

Revenue Net Income Free Cash Flow

Metric	2020	2021	2022	2023	TTM
Revenue	$0.00	$366000.00	$0.00	$0.00	$0.00
Net income	$-197.16M	$-465.88M	$-607.51M	$-496.98M	$-496.98M
EPS	—	—	—	—	$-0.97
Free cash flow	$-277.55M	$-361.29M	$-3.64B	—	—
Profit margin	—	-127,289.62%	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GRCL	$989.87M	24	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-26.29%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Gracell Biotechnologies Inc. trades at $10.25. Our Smart Value Score of 24/100 indicates the stock is weak.

Frequently asked questions

What is Gracell Biotechnologies Inc.'s stock price?

Gracell Biotechnologies Inc. (GRCL) trades at $10.25.

Is Gracell Biotechnologies Inc. overvalued?

Smart Value Score 24/100 (Grade F, Strong Sell).

What is the price target of Gracell Biotechnologies Inc. (GRCL)?

The analyst target price is $10.58, representing +3.2% upside from the current price of $10.25.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryChina

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio732.21x

ROE-31.60%

Beta-0.35

50D MA$9.54

200D MA$5.24

Shares out0.10B

Float0.17B

Short ratio—

Avg volume6.4M

Performance

1 week+0.00%

1 month+0.00%

3 months+0.00%

YTD+0.00%

1 year+0.00%

3 years—

5 years—

Compare

GRCL vs LLY →GRCL vs JNJ →GRCL vs ABBV →Stock screener →